Medical-grade formulations from reputable sources help minimize contamination risks and ensure consistent therapeutic effects
These signs include fatigue, weakness, constipation, reduced appetite, weight loss, along with numbness and tingling sensations in the extremities
Long half-life (2030 hrs) Once-daily dosing achievable - vs
Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Faraone SV (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations
Interestingly, our results about OS biomarkers in DM2 and type 1 diabetes mellitus (DM1) showed that antioxidant therapy should not be recommended in DM1 (Nuez-Sells et al., 2019)